INTERPACE BIOSCIENCES, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Interpace Biosciences, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Interpace Biosciences, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $45K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $45K $0 0% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $45K $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $45K $0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $45K $0 0% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $45K -$35K -43.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $45K -$84K -65.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $45K -$106K -70.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $45K -$96K -68.1% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $80K -$224K -73.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $129K -$161K -55.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $151K +$109K +260% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $141K +$99K +236% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $304K +$262K +624% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $290K +$248K +590% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $42K $0 0% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $42K $0 0% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $42K $0 0% Sep 30, 2020 10-Q 2021-01-20
Q2 2020 $42K +$11K +35.5% Jun 30, 2020 10-Q/A 2021-01-19
Q1 2020 $42K +$11K +35.5% Mar 31, 2020 10-Q/A 2021-01-19
Q4 2019 $42K +$11K +35.5% Dec 31, 2019 10-K 2021-04-01
Q3 2019 $42K +$11K +35.5% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $31K $0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $31K $0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $31K $0 0% Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 $31K $0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $31K $0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $31K +$30K +3000% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $31K -$220K -87.6% Dec 31, 2017 10-K 2019-03-21
Q3 2017 $31K -$970K -96.9% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $31K -$1.1M -97.3% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $1K -$1.07M -99.9% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $251K -$3M -92.3% Dec 31, 2016 10-K 2018-03-23
Q3 2016 $1M -$3.23M -76.3% Sep 30, 2016 10-Q 2016-11-17
Q2 2016 $1.13M -$2.96M -72.4% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $1.07M -$3.18M -74.9% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $3.26M +$306K +10.4% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $4.23M +$3.13M +286% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $4.09M +$3.14M +331% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $4.25M +$3.24M +323% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $2.95M -$1.84M -38.4% Dec 31, 2014 10-K 2016-03-30
Q3 2014 $1.09M +$49K +4.69% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $948K -$234K -19.8% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1M -$60K -5.64% Mar 31, 2014 10-Q/A 2014-08-19
Q4 2013 $4.79M +$2.84M +146% Dec 31, 2013 10-K 2015-03-05
Q3 2013 $1.05M -$1.84M -63.7% Sep 30, 2013 10-Q/A 2014-09-30
Q2 2013 $1.18M -$2.63M -69% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 $1.06M -$3.21M -75.1% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $1.95M -$2.37M -55% Dec 31, 2012 10-Q/A 2014-09-30
Q3 2012 $2.88M -$2.18M -43.1% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $3.81M -$1.03M -21.2% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $4.28M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $4.32M -$1.1M -20.3% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $5.07M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $4.84M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 $5.42M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.